Firms begin study on chewable albendazole formulation

Fidson Health Care Plc has partnered with a clinical research organisation, Liddie BE Ltd to conduct a Bioequivalence (BE) study on their chewable formulation of Albendazole tablets.

by Musa Adekunle

Shareholders okay NEM’s N1.5 billion total dividend

by Guardian Nigeria

NEM Insurance posts 23% increase in net premium in 2021

by Helen Oji

‘Fidson is committed to providing affordable, high quality pharmaceuticals to Nigerians’

by Paul Adunwoke

Toyota Center In Washington State Hosts Mass Vaccination Site

Reasons most African countries won’t get COVID-19 vaccines until April

by Chukwuma Muanya

Stakeholders raise alarm as local drug manufacturing nears collapse

by Chukwuma Muanya

Delayed bailout unsettles aviation, health sectors

by Chukwuma Muanya and Wole Oyebade

Experts explain rise in prices of pharmaceuticals, others

by Chukwuma Muanya

NEM offers investors N687 million dividend

by Bankole Orimisan

Underwriter offers shareholders N687 million dividend

by Bankole Orimisan

Furore over rise in fake drugs-induced deaths, treatment failures worldwide

by Chukwuma Muanya

GSK, Fidson partner on contract manufacturing, technology transfer

by Femi Adekoya

Fidson posts N16.23 billion turnover, seeks fresh capital

by Helen Oji

Yakasai inaugurates Safe Medicines Foundation, unveils advocacy book

by Editor

NEM Insurance records N10.9b premium

by Editor

The News You Need, Delivered To You.